Clinical Trial

Clinical Efficacy of the Erchonia EVRL for Providing Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this clinical study is to determine the effectiveness of the Erchonia® EVRL™, manufactured by Erchonia Corporation (the Company), in providing prescription home use application for temporary relief of idiopathic neuropathy foot pain in individuals diagnosed with idiopathic neuropathy by a suitably qualified and licensed health professional.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-03; most recent amendment 2025-09-05.
Status change: Not Yet Recruiting → Recruiting 2025-09-05
Trial Details
NCT Number NCT06912646
Lead Sponsor Erchonia Corporation
Conditions Neuropathy, Neuropathy;Peripheral
Enrollment 32 participants
Start Date 2025-05-01
Primary Completion 2027-05-16 (estimated)
Study Completion 2027-06-16 (estimated)
Updated on ClinicalTrials.gov 2025-09-08